Skip to main content

Table 1 General characteristics of 1318 respondents

From: Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China

  Overall (n = 1318) Repro-Endo (n = 187) OB-Gyn (n = 1131) P-value
Sex
 female 1282 (97.3) 177 (94.7) 1105 (97.7) .018
 male 36 (2.7) 10 (5.3) 26 (2.3) .018
Age
 18–35 226 (17.1) 22 (11.7) 204 (18.0) .035
 36–45 514 (39.0) 76 (40.7) 438 (38.7) NS
 ≥ 46 578 (43.9) 89 (47.6) 489 (43.3) NS
Hospital grade
 3 793 (60.2) 123 (65.8) 670 (59.2) NS
 2 456 (34.6) 61 (32.6) 395 (34.9) NS
 1 69 (5.2) 3 (1.6) 66 (5.9) .016
No. of patients with PCOS treated annually
 < 50 849 (64.4) 54 (28.8) 795 (70.3) <.001
 51–200 358 (27.2) 86 (46.0) 272 (24.0) <.001
 > 200 111 (8.4) 47 (25.2) 64 (5.7) <.001
Main reason for clinic attendance in patients with PCOS
 Menstrual disorders 1062 (80.6) 130 (69.5) 932 (82.4) <.001
 Infertility 226 (17.1) 54 (29.0) 172 (15.2) <.001
 Hirsutism/acne 9 (0.7) 1 (0.5) 8 (0.7) NS
 Obesity/IR 21 (1.6) 2 (1.0) 19 (1.7) NS
Estimated national prevalence of overweight/obesity in patients with PCOS
 0–30% 384 (29.1) 28 (15.0) 356 (31.5) <.001
 31–50% 541 (41.1) 87 (46.5) 454 (40.1) NS
 51–80% 331 (25.1) 64 (34.2) 267 (23.6) .002
 > 80% 62 (4.7) 8 (4.3) 54 (4.8) NS
  1. Abbreviations: Repro-Endo Reproductive endocrinologist, OB-Gyn Obstetrician-gynecologists, PCOS Polycystic ovary syndrome